Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

NCT00113113 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astex Pharmaceuticals, Inc.